Kubesch, A.; Rueter, L.; Farrag, K.; Krause, T.; Stienecker, K.; Hausmann, J.; Filmann, N.; Dignass, A.; Stein, J.; Blumenstein, I.
Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort. J. Clin. Med. 2019, 8, 2140.
https://doi.org/10.3390/jcm8122140
AMA Style
Kubesch A, Rueter L, Farrag K, Krause T, Stienecker K, Hausmann J, Filmann N, Dignass A, Stein J, Blumenstein I.
Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort. Journal of Clinical Medicine. 2019; 8(12):2140.
https://doi.org/10.3390/jcm8122140
Chicago/Turabian Style
Kubesch, Alica, Laurenz Rueter, Karima Farrag, Thomas Krause, Klaus Stienecker, Johannes Hausmann, Natalie Filmann, Axel Dignass, Jürgen Stein, and Irina Blumenstein.
2019. "Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort" Journal of Clinical Medicine 8, no. 12: 2140.
https://doi.org/10.3390/jcm8122140
APA Style
Kubesch, A., Rueter, L., Farrag, K., Krause, T., Stienecker, K., Hausmann, J., Filmann, N., Dignass, A., Stein, J., & Blumenstein, I.
(2019). Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort. Journal of Clinical Medicine, 8(12), 2140.
https://doi.org/10.3390/jcm8122140